Physician profile
Daniel E Wildes
NPI 1932163565
$24,088.15
in general payments reported to CMS, 2019-2025
51 companies · $3,152 in 2025
The $3,152 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,132 · 2020: $1,563 · 2021: $3,167 · 2022: $3,217 · 2023: $3,737 · 2024: $4,121 · 2025: $3,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,559.51 |
| Travel and Lodging | $450.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $3,687.55 | 2022-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3,559.33 | 2019-2025 | Lifevest |
| Abbott Laboratories | $3,329.86 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Gallant |
| Boston Scientific Corporation | $3,140.33 | 2019-2025 | General - Therapies, Cds Broad Portfolio Offering, Eluvia |
| Novartis Pharmaceuticals Corporation | $1,651.79 | 2019-2025 | Leqvio |
| Philips North America LLC | $1,001.71 | 2021-2025 | (Br0) Coronary Atherectomy, (Bh4) Igt Devices Undivided, (Ck4) Mcot |
| Shockwave Medical, INC | $949.32 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $716.53 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $541.57 | 2021-2025 | Verquvo, Winrevair |
| Pfizer INC. | $504.15 | 2019-2025 | |
| Elutia, INC. | $482.50 | 2021-2023 | |
| Cathworks, INC. | $412.43 | 2024 | Ffrangio |
| Impulse Dynamics (USA) INC. | $385.78 | 2023-2025 | Optimizer, Optimizer |
| Atricure, INC. | $348.92 | 2019-2023 | |
| Penumbra, INC. | $328.66 | 2023-2025 | Indigo System |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $324.68 | 2019-2024 | Farxiga, Brilinta |
| Chiesi USA, INC. | $301.03 | 2020-2025 | Cleviprex, Kengreal |
| Surmodics, INC. | $274.31 | 2023-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Amgen INC. | $253.86 | 2019-2024 | Repatha |
| Edwards Lifesciences Corporation | $240.13 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $179.55 | 2019-2024 | Camzyos, Eliquis |
| Baxter Healthcare | $175.92 | 2019-2025 | Perclot, Hillrom - Cardiac Ambulatory Monitor, Floseal |
| Kestra Medical Technology Services, INC. | $157.59 | 2024-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.53 | 2021-2024 | Jardiance |
| Cordis US Corp. | $107.72 | 2023-2024 | Mynxgrip, Mynx Control, Radial 360 |
| Regeneron Healthcare Solutions, INC. | $100.10 | 2019 | |
| Ge Healthcare | $66.84 | 2020-2022 | |
| Lexicon Pharmaceuticals, INC. | $65.51 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $63.09 | 2021 | |
| Nuwellis, INC. | $59.29 | 2019-2021 | |
| Angiodynamics, INC. | $50.96 | 2025 | Alphavac |
| Teleflex LLC | $45.10 | 2022-2025 | Supercross, Vascband |
| Amarin Pharma, INC. | $41.64 | 2019-2021 | |
| Getinge USA Sales, LLC | $37.68 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.94 | 2021-2022 | |
| Medtronic, INC. | $36.62 | 2021-2025 | |
| Preventice Services, LLC | $29.29 | 2021 | |
| Kls-Martin L.P. | $26.90 | 2019 | |
| Depuy Synthes Sales INC. | $24.55 | 2025 | |
| W. L. Gore & Associates, INC. | $23.74 | 2022 | |
| Scpharmaceuticals INC. | $20.69 | 2024 | |
| Novo Nordisk INC | $19.14 | 2023 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $18.05 | 2019 | |
| Inari Medical, INC. | $18.02 | 2022 | |
| Aegerion Pharmaceuticals, INC. | $17.60 | 2019 | |
| Cvrx, INC. | $16.58 | 2023 | Barostim Neo System |
| Medtronic Vascular, INC. | $16.46 | 2020 | |
| Irhythm Technologies, INC. | $16.21 | 2022 | |
| Lantheus Medical Imaging, INC. | $15.68 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.63 | 2020 | |
| Davol INC. | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wildes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.